Automate Your Wheel Strategy on GCTK
With Tiblio's Option Bot, you can configure your own wheel strategy including GCTK - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol GCTK
- Rev/Share 0.0
- Book/Share 19.5155
- PB 0.3033
- Debt/Equity 0.0072
- CurrentRatio 4.8487
- ROIC -3.4549
- MktCap 3359340.0
- FreeCF/Share -33.7205
- PFCF -0.2679
- PE -0.1715
- Debt/Assets 0.0054
- DivYield 0
- ROE 3.9338
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 5
- P/B Score 5
- D/E Score 4
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Why Is This Nano-Cap Glucotrack Stock Trading Higher On Wednesday?
Published: June 25, 2025 by: Benzinga
Sentiment: Positive
Glucotrack Inc. GCTK stock traded higher on Wednesday, with a session volume of 15.91 million compared to the average of 81.7K, according to data from Benzinga Pro.
Read More
Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements
Published: June 12, 2025 by: GlobeNewsWire
Sentiment: Neutral
1-for-60 reverse stock split to become effective as of the opening of trading on June 16, 2025 Rutherford, NJ, June 12, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that it will effect a 1-for-60 reverse stock split (the “Reverse Stock Split”) of its issued and outstanding common stock par value $0.001 per share (the “Common Stock”), effective with the opening of trading on Monday, June 16, 2025. Glucotrack's Common Stock will continue to trade on …
Read More
Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor
Published: April 03, 2025 by: GlobeNewsWire
Sentiment: Neutral
Next Generation AI-Driven Analytics to Unlock Key Insights from the Ongoing Continuous Blood Glucose Monitoring Clinical Study Data Next Generation AI-Driven Analytics to Unlock Key Insights from the Ongoing Continuous Blood Glucose Monitoring Clinical Study Data
Read More
Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member
Published: February 26, 2025 by: GlobeNewsWire
Sentiment: Neutral
Leading diabetes researcher and clinician joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technology Leading diabetes researcher and clinician joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technology
Read More
About GlucoTrack, Inc. (GCTK)
- IPO Date 2013-04-25
- Website https://www.glucotrack.com
- Industry Medical - Instruments & Supplies
- CEO Paul V. Goode
- Employees 11